ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2026
Protected percutaneous coronary intervention of complex distal left main disease with Impella CP™ support.
Article in European heart journal supplements : journal of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complex distal left main (LM) coronary artery disease with bifurcation involvement and chronic total occlusion (CTO) is usually treated with coronary artery bypass grafting (CABG). Patient refusal of surgery necessitates high-risk percutaneous revascularization that may require mechanical circulatory support. Here, we present a case of a 66-year-old male with Canadian Cardiovascular Society Class III angina and preserved left ventricular ejection fraction (LVEF; 60%) who was diagnosed with severe calcified distal LM stenosis extending into the left ostial circumflex (LCx), and a proximal left anterior descending (LAD) CTO. CABG was recommended but declined by the patient and high-risk PCI was performed with haemodynamic support using Impella CP™ with SmartAssist. Lesion preparation included rotational atherectomy followed by intravascular lithotripsy of the LM, LAD, and LCx. The LAD CTO was successfully recanalized and treated with two drug-eluting stents and two drug-coated balloons. A double-kissing culotte two-stent strategy was applied for the distal LM bifurcation, guided by intravascular ultrasound. Haemodynamics remained stable, with Impella support successfully preventing instability during hypotensive phases and during extensive lesion modification of the LM using rotational atherectomy. The patient was discharged on dual antiplatelet therapy and remained free of angina with preserved LVEF and an excellent angiographic result at 6-month follow-up. This case demonstrates how Impella support enabled safe, complete revascularization of high-risk LM bifurcation CTO disease when CABG was declined. Moreover, it illustrates that protected PCI with an Impella device can provide a safe alternative to surgery in anatomically complex LM disease, ensuring procedural stability and complete revascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.